Cargando…
Studies in schizophrenia: pathophysiology and treatment
Studies on the pathophysiology of schizophrenia have implicated the limbic cortex, using postmortem, structural, and functional data, especially in the hippocampus (HC) and the anterior cingulate cortex (ACC). We have made contributions to the literature consistent with this idea: first, we describe...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181694/ https://www.ncbi.nlm.nih.gov/pubmed/22033751 |
_version_ | 1782212791280599040 |
---|---|
author | Tamminga, Carol A. Medoff, Deborah R. |
author_facet | Tamminga, Carol A. Medoff, Deborah R. |
author_sort | Tamminga, Carol A. |
collection | PubMed |
description | Studies on the pathophysiology of schizophrenia have implicated the limbic cortex, using postmortem, structural, and functional data, especially in the hippocampus (HC) and the anterior cingulate cortex (ACC). We have made contributions to the literature consistent with this idea: first, we describe a positive significant correlation between psychotic symptoms in schizophrenia and neuronal activity in the ACC and HC, suggesting the involvement of limbic cortex in the mediation of symptoms in schizophrenia. Second, in the ACC and the anterior HC (but not in the posterior HC), regional cerebral blood flow (rCBF) is abnormal (ie, reduced in the ACC and elevated in the HC) in schizophrenia. Third, the relationship of rCBF to task difficulty in the ACC is altered in schizophrenia, suggesting a failure of participation of the ACC in effortful tasks. Lastly, connectivity between the ACC and HC during the performance of an auditory discrimination task is also lacking, suggesting that cognitive performance in schizophrenia lacks a functional limbic contribution. On the basis of these changes, we studied the effects of antipsychotic drugs in these abnormal areas in persons with schizophrenia. Both first- and second-generation antipsychotics produce functional alterations in these limbic cortical areas, in the direction of normals, putatively acting through the brain's own cortical-subcortical circuits. |
format | Online Article Text |
id | pubmed-3181694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Les Laboratoires Servier |
record_format | MEDLINE/PubMed |
spelling | pubmed-31816942011-10-27 Studies in schizophrenia: pathophysiology and treatment Tamminga, Carol A. Medoff, Deborah R. Dialogues Clin Neurosci Pharmacological Aspects Studies on the pathophysiology of schizophrenia have implicated the limbic cortex, using postmortem, structural, and functional data, especially in the hippocampus (HC) and the anterior cingulate cortex (ACC). We have made contributions to the literature consistent with this idea: first, we describe a positive significant correlation between psychotic symptoms in schizophrenia and neuronal activity in the ACC and HC, suggesting the involvement of limbic cortex in the mediation of symptoms in schizophrenia. Second, in the ACC and the anterior HC (but not in the posterior HC), regional cerebral blood flow (rCBF) is abnormal (ie, reduced in the ACC and elevated in the HC) in schizophrenia. Third, the relationship of rCBF to task difficulty in the ACC is altered in schizophrenia, suggesting a failure of participation of the ACC in effortful tasks. Lastly, connectivity between the ACC and HC during the performance of an auditory discrimination task is also lacking, suggesting that cognitive performance in schizophrenia lacks a functional limbic contribution. On the basis of these changes, we studied the effects of antipsychotic drugs in these abnormal areas in persons with schizophrenia. Both first- and second-generation antipsychotics produce functional alterations in these limbic cortical areas, in the direction of normals, putatively acting through the brain's own cortical-subcortical circuits. Les Laboratoires Servier 2002-12 /pmc/articles/PMC3181694/ /pubmed/22033751 Text en Copyright: © 2002 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Pharmacological Aspects Tamminga, Carol A. Medoff, Deborah R. Studies in schizophrenia: pathophysiology and treatment |
title | Studies in schizophrenia: pathophysiology and treatment |
title_full | Studies in schizophrenia: pathophysiology and treatment |
title_fullStr | Studies in schizophrenia: pathophysiology and treatment |
title_full_unstemmed | Studies in schizophrenia: pathophysiology and treatment |
title_short | Studies in schizophrenia: pathophysiology and treatment |
title_sort | studies in schizophrenia: pathophysiology and treatment |
topic | Pharmacological Aspects |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181694/ https://www.ncbi.nlm.nih.gov/pubmed/22033751 |
work_keys_str_mv | AT tammingacarola studiesinschizophreniapathophysiologyandtreatment AT medoffdeborahr studiesinschizophreniapathophysiologyandtreatment |